Sfoglia per Autore
The genetics of nodal marginal zone lymphoma
2016 Spina, Valeria; Khiabanian, Hossein; Messina, Monica; Monti, Sara; Cascione, Luciano; Bruscaggin, Alessio; Spaccarotella, Elisa; Holmes, Antony B; Arcaini, Luca; Lucioni, Marco; Tabbò, Fabrizio; Zairis, Sakellarios; Diop, Fary; Cerri, Michaela; Chiaretti, Sabina; Marasca, Roberto; Ponzoni, Maurilio; Deaglio, Silvia; Ramponi, Antonio; Tiacci, Enrico; Pasqualucci, Laura; Paulli, Marco; Falini, Brunangelo; Inghirami, Giorgio; Bertoni, Francesco; Foa, Roberto; Rabadan, Raul; Gaidano, Gianluca; Rossi, Davide
Clinical significance of recurrent copy number aberrations in B-lineage acute lymphoblastic leukaemia without recurrent fusion genes across age cohorts
2017 Messina, Monica; Chiaretti, Sabina; Fedullo, ANNA LUCIA; Piciocchi, Alfonso; Puzzolo, Maria Cristina; Lauretti, Alessia; Gianfelici, Valentina; Apicella, Valerio; Fazi, Paola; Te Kronnie, Geertruy; Testi, Anna Maria; Vitale, Antonella; Guarini, Anna; Foa, Roberto
Prognostic implications of additional genomic lesions in adult Ph+ acute lymphoblastic leukemia
2018 Fedullo, Al; Messina, M; Elia, L; Piciocchi, A; Gianfelici, V; Lauretti, A; Soddu, S; Puzzolo, Mc; Minotti, C; Ferrara, F; Martino, B; Chiusolo, P; Calafiore, V; Paolini, S; Vignetti, M; Vitale, A; Guarini, A; Foà, R; Chiaretti, S.
New Approaches to the Management of Adult Acute Lymphoblastic Leukemia
2018 Chiaretti, Sabina
High PIM1 expression is a biomarker of T-cell acute lymphoblastic leukemia with JAK/STAT activation or t(6;7)(p21;q34)/TRB@-PIM1 rearrangement
2018 la Starza, Roberta; Messina, Monica; Gianfelici, Valentina; Pierini, Valentina; Matteucci, Caterina; Pierini, Tiziana; Limongi, Maria Zaira; Vitale, Antonella; Roti, Giovanni; Chiaretti, Sabina; Foà, Robin; Mecucci, Cristina
Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications.
2018 Chiaretti, S; Messina, M; Grammatico, S; Piciocchi, A; Fedullo, Al; Di Giacomo, F; Peragine, N; Gianfelici, Valentina; Lauretti, A; Bareja, R; Martelli, Mp; Vignetti, M; Apicella, V; Vitale, A; Li, Ls; Salek, C; Elemento, O; Inghirami, G; Weinstock, Dm; Guarini, A; Foà, R
Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms.
2018 Circosta, P; Elia, Ar; Landra, I; Machiorlatti, R; Todaro, M; Aliberti, S; Brusa, D; Deaglio, S; Chiaretti, S; Bruna, R; Gottardi, D; Massaia, M; Giacomo, Fd; Guarini, Ar; Foà, R; Kyriakides, Pw; Bareja, R; Elemento, O; Chichili, Gr; Monteleone, E; Moore, Pa; Johnson, S; Bonvini, E; Cignetti, A; Inghirami, G.
"Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions"-Treatment of ALL.
2018 Chiaretti, S; Jabbour, E; Hoelzer, D
Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
2018 Giebel, S.; Marks, D. I.; Boissel, N.; Baron, F.; Chiaretti, S.; Ciceri, F.; Cornelissen, J. J.; Doubek, M.; Esteve, J.; Fielding, A.; Foa, R.; Gorin, N. -C.; Gokbuget, N.; Hallbook, H.; Hoelzer, D.; Paravichnikova, E.; Ribera, J. -M.; Savani, B.; Rijneveld, A. W.; Schmid, C.; Wartiovaara-Kautto, U.; Mohty, M.; Nagler, A.; Dombret, H.
Chemotherapy-free and reduced intensity approaches in elderly patients with B-lineage acute lymphoblastic leukemia
2018 Chiaretti, S.; Foa, R.
IL7R overexpression in adult acute lymphoblastic leukemia is associated to JAK/STAT pathway mutations and identifies patients who could benefit from targeted therapies
2018 Gianfelici, V; Messina, M; Paoloni, F; Peragine, N; Lauretti, A; Fedullo, Al; Di Giacomo, F; Vignetti, M; Vitale, A; Guarini, A; Chiaretti, S; Foà, R.
Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia
2019 Della Starza, I.; De Novi, L. A.; Santoro, A.; Salemi, D.; Tam, W.; Cavalli, M.; Menale, Lucia; Soscia, R.; Apicella, V.; Ilari, C.; Vitale, A.; Testi, A. M.; Inghirami, G.; Chiaretti, S.; Foa, R.; Guarini, A.
Minimal residual disease in acute lymphoblastic leukemia: technical and clinical advances
2019 Starza, I. D.; Chiaretti, S.; De Propris, M. S.; Elia, L.; Cavalli, M.; De Novi, L. A.; Soscia, R.; Messina, M.; Vitale, A.; Guarini, A.; Foa, R.
Atypical chronic myeloid leukemia in a patient with aplastic anemia
2019 Santopietro, Michelina; Miano, Maurizio; Palumbo, Giovanna; Zhang, Kejian; Cardarelli, Luisa; Chiaretti, Sabina; Peragine, Nadia; Nanni, Mauro; Diverio, Daniela; Mancini, Francesca; Testi, Anna Maria; Moleti, Maria Luisa; Foà, Robin; Giona, Fiorina
BCR/ABL1–like acute lymphoblastic leukemia: How to diagnose and treat?
2019 Chiaretti, S.; Messina, M.; Foa, R.
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol
2019 Bassan, R.; Fumagalli, M.; Chiaretti, S.; Audisio, E.; Cascavilla, N.; Paolini, S.; Delia, M.; Cerqui, E.; Mico, C.; Fabbiano, F.; Canichella, M.; Scattolin, A. M.; Perfetti, P.; Paoloni, F.; Iodice, M.; Vitale, A.; Della Starza, I.; Fazi, P.; Vignetti, M.; Foa, R.
Efficacy of imatinib and chemotherapy in a pediatric patient with Philadelphia-like acute lymphoblastic leukemia with Ebf1-Pdgfrb fusion transcript
2020 Fazio, F.; Barberi, W.; Cazzaniga, G.; Fazio, G.; Messina, M.; Della Starza, I.; De Propris, M. S.; Mancini, F.; Mohamed, S.; Del Giudice, I.; Chiaretti, S.; Moleti, M. L.; Guarini, A.; Foa, R.; Testi, A. M.
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimale residual disease-oriented GIMEMA LAL1913
2020 Chiaretti, S.; Messina, M.; Della Sarza, I.; Piciocchi, A.; Cafforio, L.; Cavalli, M.; Taherinasab, A.; Ansuinelli, M.; Elia, L.; Albertini PEtroni, G.; LA Starza, R.; Canichella, M.; Lauretti, A.; Puzzolo, Mc.; Pierini, V.; Santoro, A.; Spinelli, O.; Apicella, V.; Capria, S.; Di Raimondo, F.; De Fabritiis, P.; Papayannidis, C.; Candoni, A.; Cairoli, R.; Cerrano, M.; Fracchiolla, N.; Mattei, D.; Cattaneo, C.; Vitale, A.; Crea, E.; Fazi, P.; Mecucci, C.; Rambaldi, A.; Guarini, A.; Bassan, R.; Foà, R.
Ph+ acute lymphoblastic leukaemia in italy during the covid-19 pandemic. A campus ALL study
2020 Foa, R.; Bonifacio, M.; Chiaretti, S.; Curti, A.; Candoni, A.; Fava, C.; Ciccone, M.; Pizzolo, G.; Ferrara, F.
A review of current induction strategies and emerging prognostic factors in the management of children and adolescents with acute lymphoblastic leukemia
2020 Capria, S.; Molica, M.; Mohamed, S.; Bianchi, S.; Moleti, Ml.; Trisolini, Sm.; Chiaretti, S.; Testi, Am.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The genetics of nodal marginal zone lymphoma | 2016 | Spina, Valeria; Khiabanian, Hossein; Messina, Monica; Monti, Sara; Cascione, Luciano; Bruscaggin, Alessio; Spaccarotella, Elisa; Holmes, Antony B; Arcaini, Luca; Lucioni, Marco; Tabbò, Fabrizio; Zairis, Sakellarios; Diop, Fary; Cerri, Michaela; Chiaretti, Sabina; Marasca, Roberto; Ponzoni, Maurilio; Deaglio, Silvia; Ramponi, Antonio; Tiacci, Enrico; Pasqualucci, Laura; Paulli, Marco; Falini, Brunangelo; Inghirami, Giorgio; Bertoni, Francesco; Foa, Roberto; Rabadan, Raul; Gaidano, Gianluca; Rossi, Davide | |
| Clinical significance of recurrent copy number aberrations in B-lineage acute lymphoblastic leukaemia without recurrent fusion genes across age cohorts | 2017 | Messina, Monica; Chiaretti, Sabina; Fedullo, ANNA LUCIA; Piciocchi, Alfonso; Puzzolo, Maria Cristina; Lauretti, Alessia; Gianfelici, Valentina; Apicella, Valerio; Fazi, Paola; Te Kronnie, Geertruy; Testi, Anna Maria; Vitale, Antonella; Guarini, Anna; Foa, Roberto | |
| Prognostic implications of additional genomic lesions in adult Ph+ acute lymphoblastic leukemia | 2018 | Fedullo, Al; Messina, M; Elia, L; Piciocchi, A; Gianfelici, V; Lauretti, A; Soddu, S; Puzzolo, Mc; Minotti, C; Ferrara, F; Martino, B; Chiusolo, P; Calafiore, V; Paolini, S; Vignetti, M; Vitale, A; Guarini, A; Foà, R; Chiaretti, S. | |
| New Approaches to the Management of Adult Acute Lymphoblastic Leukemia | 2018 | Chiaretti, Sabina | |
| High PIM1 expression is a biomarker of T-cell acute lymphoblastic leukemia with JAK/STAT activation or t(6;7)(p21;q34)/TRB@-PIM1 rearrangement | 2018 | la Starza, Roberta; Messina, Monica; Gianfelici, Valentina; Pierini, Valentina; Matteucci, Caterina; Pierini, Tiziana; Limongi, Maria Zaira; Vitale, Antonella; Roti, Giovanni; Chiaretti, Sabina; Foà, Robin; Mecucci, Cristina | |
| Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications. | 2018 | Chiaretti, S; Messina, M; Grammatico, S; Piciocchi, A; Fedullo, Al; Di Giacomo, F; Peragine, N; Gianfelici, Valentina; Lauretti, A; Bareja, R; Martelli, Mp; Vignetti, M; Apicella, V; Vitale, A; Li, Ls; Salek, C; Elemento, O; Inghirami, G; Weinstock, Dm; Guarini, A; Foà, R | |
| Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms. | 2018 | Circosta, P; Elia, Ar; Landra, I; Machiorlatti, R; Todaro, M; Aliberti, S; Brusa, D; Deaglio, S; Chiaretti, S; Bruna, R; Gottardi, D; Massaia, M; Giacomo, Fd; Guarini, Ar; Foà, R; Kyriakides, Pw; Bareja, R; Elemento, O; Chichili, Gr; Monteleone, E; Moore, Pa; Johnson, S; Bonvini, E; Cignetti, A; Inghirami, G. | |
| "Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions"-Treatment of ALL. | 2018 | Chiaretti, S; Jabbour, E; Hoelzer, D | |
| Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) | 2018 | Giebel, S.; Marks, D. I.; Boissel, N.; Baron, F.; Chiaretti, S.; Ciceri, F.; Cornelissen, J. J.; Doubek, M.; Esteve, J.; Fielding, A.; Foa, R.; Gorin, N. -C.; Gokbuget, N.; Hallbook, H.; Hoelzer, D.; Paravichnikova, E.; Ribera, J. -M.; Savani, B.; Rijneveld, A. W.; Schmid, C.; Wartiovaara-Kautto, U.; Mohty, M.; Nagler, A.; Dombret, H. | |
| Chemotherapy-free and reduced intensity approaches in elderly patients with B-lineage acute lymphoblastic leukemia | 2018 | Chiaretti, S.; Foa, R. | |
| IL7R overexpression in adult acute lymphoblastic leukemia is associated to JAK/STAT pathway mutations and identifies patients who could benefit from targeted therapies | 2018 | Gianfelici, V; Messina, M; Paoloni, F; Peragine, N; Lauretti, A; Fedullo, Al; Di Giacomo, F; Vignetti, M; Vitale, A; Guarini, A; Chiaretti, S; Foà, R. | |
| Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia | 2019 | Della Starza, I.; De Novi, L. A.; Santoro, A.; Salemi, D.; Tam, W.; Cavalli, M.; Menale, Lucia; Soscia, R.; Apicella, V.; Ilari, C.; Vitale, A.; Testi, A. M.; Inghirami, G.; Chiaretti, S.; Foa, R.; Guarini, A. | |
| Minimal residual disease in acute lymphoblastic leukemia: technical and clinical advances | 2019 | Starza, I. D.; Chiaretti, S.; De Propris, M. S.; Elia, L.; Cavalli, M.; De Novi, L. A.; Soscia, R.; Messina, M.; Vitale, A.; Guarini, A.; Foa, R. | |
| Atypical chronic myeloid leukemia in a patient with aplastic anemia | 2019 | Santopietro, Michelina; Miano, Maurizio; Palumbo, Giovanna; Zhang, Kejian; Cardarelli, Luisa; Chiaretti, Sabina; Peragine, Nadia; Nanni, Mauro; Diverio, Daniela; Mancini, Francesca; Testi, Anna Maria; Moleti, Maria Luisa; Foà, Robin; Giona, Fiorina | |
| BCR/ABL1–like acute lymphoblastic leukemia: How to diagnose and treat? | 2019 | Chiaretti, S.; Messina, M.; Foa, R. | |
| Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol | 2019 | Bassan, R.; Fumagalli, M.; Chiaretti, S.; Audisio, E.; Cascavilla, N.; Paolini, S.; Delia, M.; Cerqui, E.; Mico, C.; Fabbiano, F.; Canichella, M.; Scattolin, A. M.; Perfetti, P.; Paoloni, F.; Iodice, M.; Vitale, A.; Della Starza, I.; Fazi, P.; Vignetti, M.; Foa, R. | |
| Efficacy of imatinib and chemotherapy in a pediatric patient with Philadelphia-like acute lymphoblastic leukemia with Ebf1-Pdgfrb fusion transcript | 2020 | Fazio, F.; Barberi, W.; Cazzaniga, G.; Fazio, G.; Messina, M.; Della Starza, I.; De Propris, M. S.; Mancini, F.; Mohamed, S.; Del Giudice, I.; Chiaretti, S.; Moleti, M. L.; Guarini, A.; Foa, R.; Testi, A. M. | |
| Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimale residual disease-oriented GIMEMA LAL1913 | 2020 | Chiaretti, S.; Messina, M.; Della Sarza, I.; Piciocchi, A.; Cafforio, L.; Cavalli, M.; Taherinasab, A.; Ansuinelli, M.; Elia, L.; Albertini PEtroni, G.; LA Starza, R.; Canichella, M.; Lauretti, A.; Puzzolo, Mc.; Pierini, V.; Santoro, A.; Spinelli, O.; Apicella, V.; Capria, S.; Di Raimondo, F.; De Fabritiis, P.; Papayannidis, C.; Candoni, A.; Cairoli, R.; Cerrano, M.; Fracchiolla, N.; Mattei, D.; Cattaneo, C.; Vitale, A.; Crea, E.; Fazi, P.; Mecucci, C.; Rambaldi, A.; Guarini, A.; Bassan, R.; Foà, R. | |
| Ph+ acute lymphoblastic leukaemia in italy during the covid-19 pandemic. A campus ALL study | 2020 | Foa, R.; Bonifacio, M.; Chiaretti, S.; Curti, A.; Candoni, A.; Fava, C.; Ciccone, M.; Pizzolo, G.; Ferrara, F. | |
| A review of current induction strategies and emerging prognostic factors in the management of children and adolescents with acute lymphoblastic leukemia | 2020 | Capria, S.; Molica, M.; Mohamed, S.; Bianchi, S.; Moleti, Ml.; Trisolini, Sm.; Chiaretti, S.; Testi, Am. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile